All news from Ophthalmology

Making Moves to Understand Cognitive Function in the Brain

The cerebellum, a structure found in the back of the skull, is known to be important for the control of movement, while the frontal cortex is responsible for cognitive functions such as short-term memory and decision making. However, as the scientists continue to unlock the mystery of how billions of neurons in the brain interact, it is becoming more apparent that it is not that black and white

Dust-Dwelling Bacteria: Letting In the Sunlight Kills them

Allowing sunlight in through windows can kill bacteria that live in dust, according to a study published in the open access journal MicrobiomeResearchers at the University of Oregon found that in dark rooms 12% of bacteria on average were alive and able to reproduce (viable). In comparison only 6.8% of bacteria exposed to daylight and 6.1% of bacteria exposed to UV light were viable.

Pathogenic Bacteria: New Diagnostic Platform Simultaneously Screens All

Scientists at the Center for Infection and Immunity (CII) in the Columbia University Mailman School of Public Health have developed the first diagnostic platform that can simultaneously screen for all human pathogenic bacteria as well as markers for virulence and antibiotic resistance. A study in the journal mBio provides details on the performance of the BacCapSeq platform.

First New Type of Flu Drug Approved by the US in 2 Decades

US health regulators have approved the first new type of flu drug in decades. Approval of Xofluza for people age 12 and older comes ahead of the brunt of this winter's flu season. Xofluza is a pill that can reduce the severity and shorten duration of flu symptoms after one just dose. It was developed by the Roche Group and Shionogi & Co. It works about as well as Tamiflu, Roche's older flu treatment, which is also available in cheaper generic versions. Tamiflu is taken twice daily for five days.

We're doing drug trials wrong – here's how to fix it

By the age of 65, at least half of us will suffer from two or more long-term diseases. And the chance of having multi-morbidity, as it is known, increases with age. Only 9% of people with coronary heart disease have no other condition. The other 91% have various combinations of hypertension (high blood pressure), heart failure, stroke, diabetes, chronic obstructive pulmonary disease, depression, dementia, chronic kidney disease and so on.